SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech for less than a buck. -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (196)12/1/1999 8:55:00 AM
From: Softechie  Read Replies (1) | Respond to of 743
 
Richard...I know what I see from filings and talking to Avanir people. At this time they're working hard on partnership deal and there are 8 companies negotiating with Avanir. If no partner, Avanir is dead in the water. However the market is huge and it's 100% we will get a partner. Also Docosanol works on indications of herpes and coldsores. Check the stats for efficacy. The latest SEC filing shows that they have received the $1.5M bridge loan.



To: scaram(o)uche who wrote (196)12/3/1999 1:42:00 AM
From: luis a. garcia  Read Replies (2) | Respond to of 743
 
Richard seems to me you have an axe to grind here... but in any case the drug works and works for indications beyound cold sores. Folks have refered to this drug as a miracle drug other folks believe is a good drug.
No matter the drug will have to ultimatelly prove to folks how well it works and when it does you will be sitting in the sidelines having stepped on your own dick.
regards
luis


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News